Electrospray ionization mass spectrometry analysis of lysophospholipids in human ascitic fluids: Comparison of the lysophospholipid contents in malignant vs nonmalignant ascitic fluids

被引:200
作者
Xiao, YJ
Schwartz, B
Washington, M
Kennedy, A
Webster, K
Belinson, J
Xu, Y
机构
[1] Cleveland Clin Fdn, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA
[2] Cleveland Clin Fdn, Lerner Res Inst, Dept Gynecol & Obstet, Cleveland, OH 44195 USA
关键词
D O I
10.1006/abio.2001.5000
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Lysophospholipids (lyso-PLs), including various glycerol-based and sphingosine-based lysophospholipids, play important roles in many biochemical, physiological, and pathological processes. The classical methods to analyze these Lipids involve gas chromatography and/or high-performance liquid chromatography, which are time-consuming, cumbersome, and sometimes inaccurate due to the incomplete separation of closely related lipid species. We now describe the quantitative analysis of lyso-PLs in ascites samples from patients with ovarian cancer using electrospray ionization spectrometry. Three new classes of lyso-PL molecules are detected: nUrvl-LPA, alkenyl-LPA, and methylated lysophosphatidylethanolamine. Importantly, the following lysophospholipid species are significantly increased in ascites from patients with ovarian cancer, compared to patients with nonmalignant diseases (e.g., Liver failure): LPA (including acyl-, Alkyl-, and alkenyl-LPA species), lysophosphatidylinositol, and sphingosylphosphorylcholine. Lysophosphorylcholine contents are also significantly different among ascitic fluids from the two groups of patients. However, the total phosphate content in ascites samples from patients with ovarian cancer is not significantly different compared to that from patients with nonmalignant disease. (C) 2001 Academic Press.
引用
收藏
页码:302 / 313
页数:12
相关论文
共 28 条
  • [1] Human ovarian cancer of the surface epithelium
    Berchuck, A
    Carney, M
    [J]. BIOCHEMICAL PHARMACOLOGY, 1997, 54 (05) : 541 - 544
  • [2] Bookman MA, 1998, SEMIN ONCOL, V25, P381
  • [3] HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY OF METHYLATED PHOSPHOLIPIDS
    CHEN, SSH
    KOU, AY
    [J]. JOURNAL OF CHROMATOGRAPHY, 1982, 232 (02): : 237 - 249
  • [4] Naturally occurring analogs of lysophosphatidic acid elicit different cellular responses through selective activation of multiple receptor subtypes
    Fischer, DJ
    Liliom, K
    Guo, Z
    Nusser, N
    Virág, T
    Murakami-Murofushi, K
    Kobayashi, S
    Erickson, JR
    Sun, GP
    Miller, DD
    Tigyi, G
    [J]. MOLECULAR PHARMACOLOGY, 1998, 54 (06) : 979 - 988
  • [5] Molecular diversity of sphingolipid signalling
    Heringdorf, DMZ
    vanKoppen, CJ
    Jakobs, KH
    [J]. FEBS LETTERS, 1997, 410 (01) : 34 - 38
  • [6] PHOSPHOLIPID METHYLATION AND BIOLOGICAL SIGNAL TRANSMISSION
    HIRATA, F
    AXELROD, J
    [J]. SCIENCE, 1980, 209 (4461) : 1082 - 1090
  • [7] Sphingosine-1-phosphate modulates growth and adhesion of ovarian cancer cells
    Hong, GY
    Baudhuin, LM
    Xu, Y
    [J]. FEBS LETTERS, 1999, 460 (03) : 513 - 518
  • [8] Identification of a novel growth factor-like lipid, 1-O-cis-alk-1′-enyl-2-lyso-sn-glycero-3-phosphate (alkenyl-GP) that is present in commercial sphingolipid preparations
    Liliom, K
    Fischer, DJ
    Virág, T
    Sun, GP
    Miller, DD
    Tseng, JL
    Desiderio, DM
    Seidel, MC
    Erickson, JR
    Tigyi, G
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (22) : 13461 - 13468
  • [9] Xenopus oocytes express multiple receptors for LPA-like lipid mediators
    Liliom, K
    MurakamiMurofushi, K
    Kobayashi, S
    Murofushi, H
    Tigyi, G
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1996, 270 (03): : C772 - C777
  • [10] LIPID 2ND MESSENGERS
    LISCOVITCH, M
    CANTLEY, LC
    [J]. CELL, 1994, 77 (03) : 329 - 334